Pro-Pharmaceuticals Receives Amex Non-Compliance Notice (Business Wire)

yahoo.com     May 20, 2008            

NEWTON, Mass.----Pro-Pharmaceuticals, Inc. , a developer of first-in-class, carbohydrate-based targeted therapeutic compounds to treat cancer and liver fibrosis, today announced the American Stock Exchange notified the Company that it does not meet a continued listing standard because it has less... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies